Close Menu

PerkinElmer

San Francisco Ferry Building

Executives provided updates on their companies at the 35th Annual JP Morgan Healthcare Conference in San Francisco.

Tulip Diagnostics Private provides in vitro diagnostic reagents, kits, and instruments to labs, and government and private healthcare facilities in India.

The companies will merge 10x's Chromium system and PerkinElmer's automation solutions into a combined NGS solution for researchers.

The company said the divestiture to Varian Medical Systems would allow it to concentrate on investing in high-growth parts of its business.

The company reported drops in revenues for both its human health and environmental health units, blaming challenging market conditions for the decreases.

Several academic and commercial groups are developing clinical cell-based noninvasive prenatal tests, which could eventually compete with current cell-free NIPTs.

The company said the diagnostics unit will be focused on reproductive health, diagnostics for emerging markets, and applied genomics.

The company said it will use the proceeds for various purposes, including working capital, capital expenditures, stock repurchases, dividends, and acquisitions.

Revenues rose thank to an increase in the company's human health business, which offset a decline in its environmental health segment.

The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable.

Pages

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.